| Joshua Gettinger, MD | |
|
123 Hendersonville Rd, Asheville, NC 28803 | |
| (828) 257-4730 | |
| (828) 257-4738 |
| Full Name | Joshua Gettinger |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 48 Years |
| Location | 123 Hendersonville Rd, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174571855 | NPI | - | NPPES |
| 3177036 | Medicaid | TN | |
| 5922095 | Medicaid | NC | |
| 3177031 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 12243 (Tennessee) | Secondary |
| 207Q00000X | Family Medicine | 9700565 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain Area Health Education Center Inc | 0143206599 | 129 |
News Archive
More scientific research into the metabolism of stromal support cells and immune cells - and the role of the metabolism of these cell types in the development of diseases - could open new therapeutic avenues for diabetes, inflammatory conditions and cancer. That was the conclusion of a review article by scientists from VIB and KU Leuven in the leading journal Nature.
NanoSmart Pharmaceuticals, Inc., a private pharmaceutical company developing nanoparticle drug delivery platforms, has received Orphan Drug Designation from the Food and Drug Administration for one of its lead candidates, antinuclear antibody (ANA) conjugated liposomal doxorubicin.
The emergency evacuation plans of nursing homes located in the Gulf States during four hurricanes within the past year met federal and state regulations but had a number of problems, according to a report issued on Friday by HHS Inspector General Daniel Levinson, the New York Times reports.
One promising way to treat diseased or damaged kidneys is cell therapies that include the transplantation of renal progenitor cells, which can then develop into the cells needed for full recovery. Acquiring a sufficient number of progenitor cells has been difficult, however, which is why scientists have considered induced pluripotent stem cells (iPSCs), since they can be expanded at significantly high levels and then differentiated into the progenitors.
Previous estimates of levels of dementia in the developing world may have substantially underestimated the problem, according to research published today. The findings suggest that policymakers in low-income and middle-income countries may need to re-examine the burden and impact that dementia places on their health services.
› Verified 4 days ago
| Entity Name | Mountain Area Health Education Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952356388 PECOS PAC ID: 0143206599 Enrollment ID: O20040625000988 |
News Archive
More scientific research into the metabolism of stromal support cells and immune cells - and the role of the metabolism of these cell types in the development of diseases - could open new therapeutic avenues for diabetes, inflammatory conditions and cancer. That was the conclusion of a review article by scientists from VIB and KU Leuven in the leading journal Nature.
NanoSmart Pharmaceuticals, Inc., a private pharmaceutical company developing nanoparticle drug delivery platforms, has received Orphan Drug Designation from the Food and Drug Administration for one of its lead candidates, antinuclear antibody (ANA) conjugated liposomal doxorubicin.
The emergency evacuation plans of nursing homes located in the Gulf States during four hurricanes within the past year met federal and state regulations but had a number of problems, according to a report issued on Friday by HHS Inspector General Daniel Levinson, the New York Times reports.
One promising way to treat diseased or damaged kidneys is cell therapies that include the transplantation of renal progenitor cells, which can then develop into the cells needed for full recovery. Acquiring a sufficient number of progenitor cells has been difficult, however, which is why scientists have considered induced pluripotent stem cells (iPSCs), since they can be expanded at significantly high levels and then differentiated into the progenitors.
Previous estimates of levels of dementia in the developing world may have substantially underestimated the problem, according to research published today. The findings suggest that policymakers in low-income and middle-income countries may need to re-examine the burden and impact that dementia places on their health services.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Gettinger, MD 119 Hendersonville Rd, Asheville, NC 28803-2868 Ph: (828) 257-4730 | Joshua Gettinger, MD 123 Hendersonville Rd, Asheville, NC 28803 Ph: (828) 257-4730 |
News Archive
More scientific research into the metabolism of stromal support cells and immune cells - and the role of the metabolism of these cell types in the development of diseases - could open new therapeutic avenues for diabetes, inflammatory conditions and cancer. That was the conclusion of a review article by scientists from VIB and KU Leuven in the leading journal Nature.
NanoSmart Pharmaceuticals, Inc., a private pharmaceutical company developing nanoparticle drug delivery platforms, has received Orphan Drug Designation from the Food and Drug Administration for one of its lead candidates, antinuclear antibody (ANA) conjugated liposomal doxorubicin.
The emergency evacuation plans of nursing homes located in the Gulf States during four hurricanes within the past year met federal and state regulations but had a number of problems, according to a report issued on Friday by HHS Inspector General Daniel Levinson, the New York Times reports.
One promising way to treat diseased or damaged kidneys is cell therapies that include the transplantation of renal progenitor cells, which can then develop into the cells needed for full recovery. Acquiring a sufficient number of progenitor cells has been difficult, however, which is why scientists have considered induced pluripotent stem cells (iPSCs), since they can be expanded at significantly high levels and then differentiated into the progenitors.
Previous estimates of levels of dementia in the developing world may have substantially underestimated the problem, according to research published today. The findings suggest that policymakers in low-income and middle-income countries may need to re-examine the burden and impact that dementia places on their health services.
› Verified 4 days ago
Caroline Knox, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-4411 Fax: 866-285-9740 | |
John M. Lang, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Town Square Blvd, Suite 220, Asheville, NC 28803 Phone: 828-654-5012 Fax: 828-654-5014 | |
Katherine Danielle Lott, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 | |
Dr. Dru Van Wilkes, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 Fax: 828-299-5854 | |
David A Wells, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 Fax: 828-299-5962 | |
Alan Sol Baumgarten, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 Hendersonville Rd, Asheville, NC 28803 Phone: 828-257-4730 | |
Karen Ledwith Dedman, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 90 Southside Ave, Suite 350, Asheville, NC 28801 Phone: 828-277-4810 |